Document Detail

Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare- Metal Stents and Different Types of Drug-Eluting Stents.
MedLine Citation:
PMID:  22946865     Owner:  NLM     Status:  Publisher    
Dual antiplatelet therapy (DAPT) with a thienopyridine and aspirin has been the standard of care post coronary stent implantation. DAPT has been shown to reduce the risk of stent thrombosis (ST) and complications of myocardial infarction and death after placement of a drug-eluting stent (DES) and bare-metal stent (BMS).This article reviews the available clinical efficacy and safety data of antiplatelet therapies. The aim of this review is to highlight not only the importance of antiplatelets in the prevention of early and late thrombosis but also emphasize the importance of newer more potent antiplatelet agents and their role in the setting of clopidogrel resistance. MEDLINE, and EMBASE were searched for studies related to the clinical efficacy and safety of antiplatelet therapy after DES and BMS placement using the terms dual antiplatelet therapy, thienopyridine, aspirin, clopidogrel, prasugrel, ticagrelor,elinogrel, bare-metal stents, drug-eluting stent, stent thrombosis and myocardial infarction.
Tarunjit Singh; Linda Cuomo; Martin Cohen; Hasan A Ahmad; Wilbert S Aronow
Related Documents :
19176635 - A population-based study of the drug interaction between proton pump inhibitors and clo...
11738775 - Pathological features of witnessed out-of-hospital cardiac arrest presenting with ventr...
8339405 - Determinants of 6-month mortality in survivors of myocardial infarction after thromboly...
16209965 - Determinants of coronary events in patients with stable angina: results from the impact...
21241965 - Effects of short-term anti-inflammatory therapy on endothelial function in patients wit...
7448835 - Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-29
Journal Detail:
Title:  Current clinical pharmacology     Volume:  -     ISSN:  2212-3938     ISO Abbreviation:  Curr Clin Pharmacol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-9-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101273158     Medline TA:  Curr Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Cardiology Division, New York Medical College Macy Pavilion, Room 138 Valhalla, NY 10595.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of an educational programme for family members of patients living with heart failure: a r...
Next Document:  Neglected Aspects of Drug Discovery-Microbiological Aspects.